Effect of 17β-estradiol on inhibition of platelet aggregation in vitro is mediated by an increase in NO synthesis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 6, 1998, Pages 961-967

  Nakano, Yukiko ^a   Oshima, Tetsuya ^a   Matsuura, Hideo ^a   Kajiyama, Goro ^a   Kambe, Masayuki ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

17 estradiol; c GMP; Intracellular Ca2+; Nitric oxide; Platelet aggregation

Indexed keywords

ESTRADIOL; NITRIC OXIDE; ANTITHROMBOCYTIC AGENT; CALCIUM; CYCLIC AMP; CYCLIC GMP;

ADULT; ARTICLE; CALCIUM CELL LEVEL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY THROMBOSIS; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; BIOSYNTHESIS; METABOLISM; THROMBOCYTE;

ADULT; BLOOD PLATELETS; CALCIUM; CYCLIC AMP; CYCLIC GMP; ESTRADIOL; FEMALE; HUMANS; MALE; NITRIC OXIDE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS;

EID: 0031595187     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.6.961     Document Type: Article

References (15)

1. Barrett-Conner E, Bush TL. Estrogen and coronary heart disease in women. JAMA. 1991;265:1861-1867.
2. Sullivan JM, Vander-Zwaag R, Lamp GF, Hughes JP, Maddock V, Kroetz FW, Ramanathan KB, Minis DM. Postmenopausal estrogen use and coronary atherosclerosis. Ann Intern Med. 1988;108:358-363.
3. Stampfer MJ, Golditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen therapy and cardiovascular disease. N Engl J Med. 1991;325:756-762.
4. The PEPI Trial Group. Effect of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA. 1995;273: 199-208.
5. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of lipoproteins. N Engl J Med. 1991;325:1196-1204.
6. Sacks FM, McPherson R, Walsh BW. Effect of postmenopausal estrogen replacement on plasma Lp(a) lipoprotein concentrations. Arch Intern Med. 1994;154:1106-1110.
7. Sarrel PM. Effect of ovarian steroids on the cardiovascular system. In: Ginsburg J, ed. Circulation in the Female. Park Ridge, NJ: Parthenon; 1989:117-140.
8. Rosselli M, Imthum B, Keller PJ, Jackson EK, Dubey RK. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β-estradiol and norethisterone acetate: a two-year follow-up study. Hypertension. 1995;25(part 2):848-853.
9. Williams JK, Adams MR, Herrington DM, Clarkson TB. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol. 1992;20:452-457.
10. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO. Acute vascular effects of estrogen in postmenopausal women. Circulation. 1994;90:786-791.
11. 2+ release induced by thromboxane A2 in porcine coronary artery. Circulation. 1995;91:2619-2626.
12. Stadel B V. Oral contraceptives and cardiovascular disease. N Engl J Med. 1981;305:612-618.
13. Goldzieher JW. Are low-dose oral contraceptives safer and better? Am J Obstet Gynecol. 1995;172:1948-1950.
14. Hirsh J. Hyperreactive platelets and complications of coronary artery disease. N Engl J Med. 1989;316:1543-1544.
15. Willerson JT, Golino P, Eidt J, Campbell WB, Buja LM. Specific platelet mediators and unstable coronary artery lesions: experimental evidence and potential clinical implications. Circulation. 1989;80:198-205.